Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.060
-0.010 (-0.93%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Revelation Biosciences Employees
Revelation Biosciences had 9 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,389,418
Market Cap
4.14M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9 | 0 | - | 8 | 1 |
| Dec 31, 2024 | 9 | -1 | -10.00% | 8 | 1 |
| Dec 31, 2023 | 10 | 4 | 66.67% | 9 | 1 |
| Dec 31, 2022 | 6 | - | - | 6 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| PMGC Holdings | 34 |
| Cardio Diagnostics Holdings | 17 |
| FibroBiologics | 15 |
| Genprex | 13 |
| Ensysce Biosciences | 10 |
| Enveric Biosciences | 6 |
| Alzamend Neuro | 6 |
| Mustang Bio | 4 |
REVB News
- 3 days ago - Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Accesswire
- 14 days ago - Revelation Biosciences Announces Adoption of Stockholder Rights Plan - Accesswire
- 5 weeks ago - Revelation Biosciences Transcript: Transcript - Transcripts
- 6 weeks ago - Revelation Biosciences Earnings release - Filings
- 6 weeks ago - Revelation Biosciences Earnings release - Filings
- 7 weeks ago - Revelation Biosciences adds two new members to AKI Advisory Board - TheFly
- 7 weeks ago - Revelation Biosciences Expands Acute Kidney Injury Advisory Board - Accesswire
- 2 months ago - Revelation Biosciences reports FY25 EPS ($14.35) vs ($1,052.16) last year - TheFly